Anbio Biotechnology (NNNN) Cash & Equivalents (2023 - 2025)
Anbio Biotechnology's quarterly Cash & Equivalents came in at $7.8 million in Q4 2025, down 33.96% year-on-year from $11.8 million in Q4 2024, and down 33.96% quarter-over-quarter from $11.8 million in Q4 2024.
Anbio Biotechnology has reported Cash & Equivalents for 3 years, with the latest figure at $7.8 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents fell 33.96% year-over-year to $7.8 million; the trailing twelve-month figure through Dec 2025 stood at $7.8 million (down 33.96% YoY), and the FY2025 full-year result was $7.8 million, down 33.96% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $7.8 million, down from $11.8 million in the prior quarter.
- The five-year high for Cash & Equivalents was $11.8 million in Q4 2024, with the low at $7.8 million in Q4 2025.
- Average Cash & Equivalents over 3 years is $9.7 million, with a median of $9.7 million recorded in 2023.
- Year-over-year, Cash & Equivalents grew 21.4% in 2024 and tumbled 33.96% in 2025.
- Tracing NNNN's Cash & Equivalents over 3 years: stood at $9.7 million in 2023, then climbed by 21.4% to $11.8 million in 2024, then plunged by 33.96% to $7.8 million in 2025.
- The last three Cash & Equivalents figures came in at $7.8 million (Q4 2025), $11.8 million (Q4 2024), and $9.7 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 2.01 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 813.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 1.66 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 521.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 561.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 124.90 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 1.06 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.02 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 222.53 Mn |
| 10 | Anbio Biotechnology | 1.32 Bn | 1.31 Bn | - | 7.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.77 Mn |
| Jun 30, 2025 | 5,348.49 Bn |
| Dec 31, 2024 | 11.76 Mn |
| Dec 31, 2023 | 9.69 Mn |